Working to Eradicate Gynecologic Cancers

288
Evaluating anti-cancer activity of a novel p53 derived peptide against multidrug resistant ovarian cancer

Saturday, March 28, 2015: 9:55 AM
Salon C-D (Hilton Chicago)
M. F. Shaikh1, D. Zimmerman1, K. Davitt1, E. M. Gleeson1, P. Love1, B. D. Babcock1, M. R. Pincus2, W. B. Bowne1, S. D. Richard1 and A. R. Desai1
1Hahnemann University Hospital/Drexel University College of Medicine, Philadelphia, PA, 2SUNY Downstate, Brooklyn, NY
 
 
See more of: Poster Session A
See more of: Poster Session
<< Previous Presentation | Next Presentation >>